TR200202033T2 - Epilepsi Tedavisi İçin Terkipler ve Yöntemler - Google Patents
Epilepsi Tedavisi İçin Terkipler ve YöntemlerInfo
- Publication number
- TR200202033T2 TR200202033T2 TR2002/02033T TR200202033T TR200202033T2 TR 200202033 T2 TR200202033 T2 TR 200202033T2 TR 2002/02033 T TR2002/02033 T TR 2002/02033T TR 200202033 T TR200202033 T TR 200202033T TR 200202033 T2 TR200202033 T2 TR 200202033T2
- Authority
- TR
- Turkey
- Prior art keywords
- preparations
- methods
- epilepsy treatment
- mammal
- epilepsy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Bir epileptik durumu olan bir memelinin tedavisi için;söz konusu memeliye etkili miktarda bir N-fenil ikameli 2-piridon bilesimi ve/veya farmasötik olarak kabul edilebilir tuzlarini içeren bir farmasötik terkibin verilmesini içeren bir yöntem
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2000/005221 WO2001062253A1 (en) | 2000-02-21 | 2000-02-21 | Compositions and methods for treatment of epilepsy |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200202033T2 true TR200202033T2 (tr) | 2003-01-21 |
Family
ID=21741103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/02033T TR200202033T2 (tr) | 2000-02-21 | 2000-02-21 | Epilepsi Tedavisi İçin Terkipler ve Yöntemler |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1261338B1 (tr) |
JP (1) | JP2003523391A (tr) |
KR (1) | KR20020081334A (tr) |
AU (2) | AU2000237125B2 (tr) |
CA (1) | CA2400491A1 (tr) |
DE (1) | DE60028831D1 (tr) |
IL (1) | IL151403A0 (tr) |
MX (1) | MXPA02008132A (tr) |
NO (1) | NO20023944L (tr) |
TR (1) | TR200202033T2 (tr) |
WO (1) | WO2001062253A1 (tr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7825133B2 (en) | 2003-11-14 | 2010-11-02 | Shanghai Genomics, Inc. | Derivatives of pyridone and the use of them |
MX2007014114A (es) | 2005-05-10 | 2008-03-14 | Intermune Inc | Derivados de piridona para modular el sistema de proteina cinasa activada por estres. |
ES2358297T3 (es) * | 2006-06-05 | 2011-05-09 | Novartis Ag | Compuestos orgánicos. |
JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン, インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
JP6525437B2 (ja) | 2014-04-02 | 2019-06-05 | インターミューン, インコーポレイテッド | 抗線維性ピリジノン |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2947755A (en) * | 1959-02-05 | 1960-08-02 | Wallace & Tiernan Inc | Substituted 1-m-aminophenyl-2-pyridones |
US5962478A (en) * | 1995-09-19 | 1999-10-05 | Margolin; Solomon B. | Inhibition of tumor necrosis factor α |
ATE332135T1 (de) * | 2000-01-24 | 2006-07-15 | Solomon B Margolin | Behandlung von brustkarzinomen, astrozytomen, melanomen und verwandten tumoren |
-
2000
- 2000-02-21 IL IL15140300A patent/IL151403A0/xx unknown
- 2000-02-21 KR KR1020027010757A patent/KR20020081334A/ko not_active Application Discontinuation
- 2000-02-21 CA CA002400491A patent/CA2400491A1/en not_active Abandoned
- 2000-02-21 WO PCT/US2000/005221 patent/WO2001062253A1/en active IP Right Grant
- 2000-02-21 EP EP00915942A patent/EP1261338B1/en not_active Expired - Lifetime
- 2000-02-21 JP JP2001561319A patent/JP2003523391A/ja active Pending
- 2000-02-21 DE DE60028831T patent/DE60028831D1/de not_active Expired - Lifetime
- 2000-02-21 MX MXPA02008132A patent/MXPA02008132A/es unknown
- 2000-02-21 AU AU2000237125A patent/AU2000237125B2/en not_active Ceased
- 2000-02-21 AU AU3712500A patent/AU3712500A/xx active Pending
- 2000-02-21 TR TR2002/02033T patent/TR200202033T2/tr unknown
-
2002
- 2002-08-20 NO NO20023944A patent/NO20023944L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001062253A1 (en) | 2001-08-30 |
MXPA02008132A (es) | 2004-11-12 |
EP1261338A4 (en) | 2004-05-06 |
KR20020081334A (ko) | 2002-10-26 |
AU2000237125B2 (en) | 2005-12-08 |
IL151403A0 (en) | 2003-04-10 |
CA2400491A1 (en) | 2001-08-30 |
NO20023944D0 (no) | 2002-08-20 |
DE60028831D1 (de) | 2006-07-27 |
AU3712500A (en) | 2001-09-03 |
JP2003523391A (ja) | 2003-08-05 |
NO20023944L (no) | 2002-09-23 |
EP1261338A1 (en) | 2002-12-04 |
EP1261338B1 (en) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1169060T3 (da) | Natriumkanalblokkerpræparater og anvendelse deraf | |
EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
PL333920A1 (en) | 3-pyridyl enantiomers and their application as pain-relieving agents | |
EA200101089A1 (ru) | Новый способ лечения | |
BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
TR200202033T2 (tr) | Epilepsi Tedavisi İçin Terkipler ve Yöntemler | |
WO2001080813A3 (en) | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy | |
DK0986393T3 (da) | Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer | |
EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
TR200103561T2 (tr) | Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları | |
AU4937499A (en) | Use of succinic acid or salts thereof and method of treating insulin resistance | |
TR199801133T2 (tr) | Tip II diyabetin tedavisi veya önlenmesi için nitrik oksit (NO) sentaz inhibitörü | |
US6541495B1 (en) | Carboxylic acid derivatives as inhibitors of hyperproliferation diseases | |
NZ521518A (en) | Compositions and methods for treatment of epilepsy | |
MX9605153A (es) | Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas. | |
MX9701529A (es) | Uso de (e)-1-[4'-(2-alquilaminoetoxi)fenil]-1-(3'-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos. |